Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Mark
    Member
    • Nov 2008
    • 54

    #1

    PacBio software vcf and consensus fasta do not agree

    I'm using your "variantCaller" tool (v6) to call variants on some older RSII subread data I aligned with blasr. The reference is 14845 bp. my variantCaller command is:

    Code:
    variantCaller --algorithm arrow --log-file variantCaller.log --annotateGFF --reportEffectiveCoverage --noEvidenceConsensusCall lowercasereference --minCoverage 40 --coverage 100 --minMapQV 40 --minConfidence 10 --minReadScore 0.75 --minSnr 3.75 --minZScore -3.5 --minAccuracy 0.82  --numWorkers 5 -r ref.fa -o 129C02-vs-ref.fa.sort.vcf -o 129C02-vs-ref.fa.sort.gff -o 129C02-vs-ref.fa.sort.fasta -o 129C02-vs-ref.fa.sort.fastq 129C02-vs-ref.fa.sort.bam
    Now it is my understanding that the fasta (and fastq) output this command should reflect the differences between the reference and the reads as reported in the vcf output.

    My vcf file reports:

    Code:
    #CHROM  POS     ID      REF     ALT     QUAL    FILTER  INFO
    ref    11438   .       CA      C       25      PASS    DP=100
    However when I align the reference and this fasta output 2 1-bp deletions are observed. One is the deletion in the vcf. The other is several thousand base pairs away and is not called by variantCaller.
    This is very disturbing.

    Can you explain this?

    Thanks for your help

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2






    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...